Primary Category:
Treatment Protocols
Disease Category:
Colon, Gastrointestinal
Status:
Closed
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)
NCT#04068103
GI005 is closed to accrual, effective February 12, 2024.
